NAMS

NASDAQ · Biotechnology

Newamsterdam Pharma Co Nv

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$31.40

+0.58 (+1.88%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 91%

Hold 2 9%

Sell 0 0%

Price Target

Analyst Price Target +15.9% upside

Low Target $23.00

Average Target $36.39

High Target $47.36

Current Price $31.40

Current
$31.40

Target
$36.39

$23.00 $36.39 avg $47.36

Scenario Analysis

Bear Case

$23.00

-26.8%

Low target

Base Case

$36.39

+15.9%

Avg target

Bull Case

$47.36

+50.8%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$42.21

-25.6% from high

52-Week Low

$17.63

+78.1% from low

50-Day SMA

$34.11

-7.9% vs SMA

200-Day SMA

$28.53

+10.1% vs SMA

RSI (14)

66.1

Neutral

Target vs 52W High

$36.39

-13.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%